RxDoctor Payments Data

Jennifer Webster, MD

Family Medicine · Coos Bay, ORNPI 1184638124

Payments from drug & device makers

$823in general payments, 2019–2025

Across 21 payments — averaging $39.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$159
  • Bayer$125
  • Dexcom, Inc.$123
  • Boston Scientific$112
  • Amgen$85
  • GSK$65
  • plus $155 from 5 others

What the payments were for

  • Food & beverage$80798%
  • Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$823 in reported general payments places this provider in the 85th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$133,409
Medicare patients
206
Services billed
6,729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Avonex Pen (4 Pack)Interferon Beta-1a15$120,784
OzempicSemaglutide77$66,654
EliquisApixaban51$56,467
JardianceEmpagliflozin13$19,164
XcopriCenobamate16$18,572
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$17,252
MounjaroTirzepatide15$15,379
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,669
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,147
Incruse ElliptaUmeclidinium Bromide14$5,927
Ventolin HfaAlbuterol Sulfate54$3,263
Albuterol Sulfate HfaAlbuterol Sulfate81$3,137
Gabapentin164$2,995
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$2,717
Atorvastatin Calcium194$2,266

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$14$67,56190 claims
PfizerEliquis$61$56,46751 claims
GSKAnoro Ellipta, Trelegy Ellipta, Incruse Ellipta$65$36,84864 claims
AstraZenecaBreztri Aerosphere$40$11,14719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Coos Bay

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →